Results 121 to 130 of about 836,803 (300)

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher, Charles B. Malpas, Stuart J. McDonald, William T. O’Brien, Craig Despott, Kelly L. Bertram, Matthew P. Pase, Lukas Frontzkowski, Meng Law, Terence J. O’Brien, Lucy Vivash   +10 more
wiley   +1 more source

SURVEY ON MULTI POINT FUEL INJECTION (MPFI) ENGINE

, 2018
<p>The Multi Point Fuel Injection (MPFI) is a system or method of injecting fuel into internal combustion engine through multi ports situated on intake valve of each cylinder. It delivers an exact quantity of fuel in each cylinder at the right time.
Deepali Baban Allolkar*1, Arun Tigadi 2 & Vijay Rayar3
core   +1 more source

Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cognitive decline is a disabling and variable feature of Parkinson disease (PD). While cholinergic system degeneration is linked to cognitive impairments in PD, most prior research reported cross‐sectional associations. We aimed to fill this gap by investigating whether baseline regional cerebral vesicular acetylcholine transporter ...
Taylor Brown, Giulia Carli, Prabesh Kanel, Stiven Roytman, Jaimie Barr, Nicolaas I. Bohnen, Roger L. Albin   +6 more
wiley   +1 more source

Quantitative determination of the leaching range of in-situ leaching mining area by stagnation point

Nuclear Engineering and Technology
The leaching range is critical to the leaching efficiency, production cost and environmental effect of in-situ leaching of uranium. In this study, the groundwater dynamics of the well-site was simulated to determine the leaching range in condition of ...
Chong Zhang, Yongmei Li, Yuqing Niu, Kaixuan Tan, Tingting Xie, Yixuan Yao, Chunguang Li, Zhenzhong Liu   +7 more
doaj   +1 more source

Ultrasound-Guided Combined Greater Occipital Nerve Block at the C2 Level with Trapezius Trigger Point Injection and Supraorbital-Supratrochlear Nerve Block: More Effective on Allodynia and Disability in Chronic Migraine. [PDF]

Ann Indian Acad Neurol, 2023
Turan SA, Aydın Ş, Gözükara MG, Çabalar M.   +3 more
europepmc   +1 more source

FDG‐PET Associations With Disease Severity and Outcomes in NMDA‐Receptor IgG Autoimmune Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Patients with N‐methyl‐D‐aspartate (NMDA) receptor‐immunoglobulin G (IgG) autoimmune encephalitis (NMDAR‐IgG AE) demonstrate occipital lobe hypometabolism on baseline brain fluorodeoxyglucose‐positron emission tomography (bFDG‐PET).
Jonathan K. Lee, Jeffrey Lambe, Scott Johnson, Akua Abrah, Jennifer Bullen, Jeffrey A. Cohen, Tatchaporn Ongphichetmetha, Amy Kunchok   +7 more
wiley   +1 more source

Effect of Point Injection of Red-sage-root on the Hip Joint Function in Ischemic Femoral Head Necrosis Patients

针刺研究, 2009
Objective To observe the therapeutic effect of point injection of Danshen(Red-sage-root) for treating ischemic necrosis of femoral head in patients.Methods A total of 62 hips of ischemic femoral head necrosis were randomly divided into point-injection ...
ZHANG Hai-feng, ZHANG Shu-yan, LIU Jin-min   +2 more
doaj  

Ultrasound-guided five-point injection of botulinum toxin for patients with trapezius hypertrophy. [PDF]

J Orthop Surg Res, 2021
Chen W, Zhang X, Xu Y, Xu Z, Qin H, Zhang L.   +5 more
europepmc   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane, Giorgia Coratti, Chiara Cutrì, Antonio Varone, Riccardo Masson, Adele D'Amico, Valeria Sansone, Sonia Messina, Federica Ricci, Chiara Ticci, Claudio Bruno, Caterina Agosto, Francesca Benedetti, Antonella Pini, Sabrina Siliquini, Massimiliano Filosto, Alberto Zambon, Ilaria Bitetti, Maria Rosaria Manna, Claudia Dosi, Riccardo Zanin, Stefano Parravicini, Roberto De Sanctis, Giulia Stanca, Michela Catteruccia, Michele Tosi, Irene Mizzoni, Emilio Albamonte, Valentina Franchino, Maria Sframeli, Ilaria Cavallina, Elena Procopio, Michele Sacchini, Simone Morando, Noemi Brolatti, Federica Trucco, Gaia Scarpini, Elena Briganti, Beatrice Berti, Concetta Palermo, Daniela Leone, Stefano C. Previtali, Eugenio Mercuri, the ITASMAC working group   +43 more
wiley   +1 more source

Comparison between single point versus double point injection in supraclavicular block incidence: ulnar sparing

Background: This study compared the efficacy of single-point versus double-point injection techniques in ultrasound-guided supraclavicular brachial plexus blocks, focusing on success rate, procedural time, onset and duration of sensory and motor block ...
S., Pooja, Anil, Devika, M. S., Nishana
core   +1 more source